Dr. Hoffman is responsible for the development of commercialization opportunities for LA BioMed’s intellectual properties, capabilities and expertise.
Prior to LA BioMed, Dr. Hoffman held senior management roles (COO, CBO, VP) in business, corporate, science, and intellectual property development for biotechnology, healthcare data, medical device, and consumer product companies. As part of those efforts Dr. Hoffman drafted, and assisted in the prosecution of, over 70 patents. Most recently, he was part of the founding team at Advera Health Analytics where he developed and helped monetize big data platforms that provide real world side effect data on all FDA approved drugs.
Dr. Hoffman is a native San Diegan who earned both his B.S. in Biology and Ph.D. in Neuroscience from UC Irvine in the laboratory of Dr. Gary Lynch. His research at Irvine focused on the molecular basis of learning and memory with an emphasis on how neural cell adhesion molecules may modulate synaptic architectures